Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.1.5.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EE.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DB.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BW.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KB.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HF.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BG.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.42.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.517NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.427 (Epsilon)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.429 (Epsilon)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.166NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.99.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KT.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JC.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.334NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.359NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.302NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.222NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.434NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.467NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.110.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.23 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.9 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EE.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
DB.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BW.1.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.1.22NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BE.6NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-17507.2China
KB.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HF.1.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BG.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.42.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.517NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.427 (Epsilon)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.429 (Epsilon)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.166NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.4.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
A.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.7.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.99.1 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KT.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JC.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used